3.0.0 3008 2025-05-27T14:16:21Z 2025-05-27T14:16:21Z House H HR 2023-04-28 118 <pre>[Congressional Record Volume 169, Number 72 (Friday, April 28, 2023)][House]From the Congressional Record Online through the Government Publishing Office [<a href="https://www.gpo.gov">www.gpo.gov</a>]By Ms. JACOBS:H.R. 3008.Congress has the power to enact this legislation pursuantto the following:Section 8 of Article I of the Constitution.The single subject of this legislation is:Health-Drug Prevention[Page H2119]</pre> hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2023-05-05T15:45:56Z Referred To 2023-04-28T13:06:50Z 118 4697 HR 2023-07-21 Referred to the Subcommittee on Health. Related bill CRS 2023-05-05 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2023-04-28 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2023-04-28 Introduced in House IntroReferral Intro-H 9 Library of Congress 2023-04-28 Introduced in House IntroReferral 1000 9 Library of Congress J000305 Rep. Jacobs, Sara [D-CA-51] Sara Jacobs D CA 51 N A000376 Rep. Allred, Colin Z. [D-TX-32] Colin Allred D TX Z. 32 2023-04-28 True C001067 Rep. Clarke, Yvette D. [D-NY-9] Yvette Clarke D NY D. 9 2023-04-28 True D000399 Rep. Doggett, Lloyd [D-TX-37] LLOYD DOGGETT D TX 37 2023-04-28 True G000586 Rep. Garcia, Jesus G. "Chuy" [D-IL-4] Jesus Garcia D IL G. 4 2023-04-28 True G000551 Rep. Grijalva, Raúl M. [D-AZ-7] Raúl Grijalva D AZ M. 7 2023-04-28 True H001068 Rep. Huffman, Jared [D-CA-2] Jared Huffman D CA 2 2023-04-28 True K000389 Rep. Khanna, Ro [D-CA-17] Ro Khanna D CA 17 2023-04-28 True L000557 Rep. Larson, John B. [D-CT-1] JOHN LARSON D CT B. 1 2023-04-28 True L000551 Rep. Lee, Barbara [D-CA-12] BARBARA LEE D CA 12 2023-04-28 True M000312 Rep. McGovern, James P. [D-MA-2] JAMES MCGOVERN D MA P. 2 2023-04-28 True O000172 Rep. Ocasio-Cortez, Alexandria [D-NY-14] Alexandria Ocasio-Cortez D NY 14 2023-04-28 True P000617 Rep. Pressley, Ayanna [D-MA-7] Ayanna Pressley D MA 7 2023-04-28 True V000131 Rep. Veasey, Marc A. [D-TX-33] Marc Veasey D TX A. 33 2023-04-28 True V000081 Rep. Velazquez, Nydia M. [D-NY-7] NYDIA VELAZQUEZ D NY M. 7 2023-04-28 True W000822 Rep. Watson Coleman, Bonnie [D-NJ-12] Bonnie Watson Coleman D NJ 12 2023-04-28 True C001125 Rep. Carter, Troy [D-LA-2] Troy Carter D LA 2 2023-04-28 True N000147 Del. Norton, Eleanor Holmes [D-DC-At Large] ELEANOR NORTON D DC HOLMES 0 2023-04-28 True C001068 Rep. Cohen, Steve [D-TN-9] Steve Cohen D TN 9 2023-04-28 True C001061 Rep. Cleaver, Emanuel [D-MO-5] Emanuel Cleaver D MO 5 2023-04-28 True S000510 Rep. Smith, Adam [D-WA-9] ADAM SMITH D WA 9 2023-04-28 True B001303 Rep. Blunt Rochester, Lisa [D-DE-At Large] Lisa Blunt Rochester D DE 0 2023-04-28 True C001130 Rep. Crockett, Jasmine [D-TX-30] Jasmine Crockett D TX 30 2023-04-28 True K000382 Rep. Kuster, Ann M. [D-NH-2] Ann Kuster D NH M. 2 2023-04-28 True T000487 Rep. Tokuda, Jill N. [D-HI-2] Jill Tokuda D HI N. 2 2023-04-28 True C001134 Rep. Caraveo, Yadira [D-CO-8] Yadira Caraveo D CO 8 2023-04-28 True S001150 Rep. Schiff, Adam B. [D-CA-30] ADAM SCHIFF D CA B. 28 2023-04-28 True J000032 Rep. Jackson Lee, Sheila [D-TX-18] SHEILA JACKSON LEE D TX 18 2023-04-28 True K000394 Rep. Kim, Andy [D-NJ-3] Andy Kim D NJ 3 2023-04-28 True M001216 Rep. Mills, Cory [R-FL-7] Cory Mills R FL 7 2023-04-28 True C001066 Rep. Castor, Kathy [D-FL-14] Kathy Castor D FL 14 2023-06-05 False C001119 Rep. Craig, Angie [D-MN-2] Angie Craig D MN 2 2023-06-06 False S001208 Rep. Slotkin, Elissa [D-MI-7] Elissa Slotkin D MI 7 2023-06-12 False B000740 Rep. Bice, Stephanie I. [R-OK-5] Stephanie Bice R OK I. 5 2023-06-14 False S001168 Rep. Sarbanes, John P. [D-MD-3] John Sarbanes D MD P. 3 2023-06-15 False D000631 Rep. Dean, Madeleine [D-PA-4] Madeleine Dean D PA 4 2023-06-20 False R000579 Rep. Ryan, Patrick [D-NY-18] Patrick Ryan D NY 18 2023-06-21 False D000530 Rep. Deluzio, Christopher R. [D-PA-17] Christopher Deluzio D PA R. 17 2023-07-11 False D000629 Rep. Davids, Sharice [D-KS-3] Sharice Davids D KS 3 2023-07-11 False F000468 Rep. Fletcher, Lizzie [D-TX-7] Lizzie Fletcher D TX 7 2023-07-11 False C001097 Rep. Cárdenas, Tony [D-CA-29] Tony Cárdenas D CA 29 2023-07-17 False P000608 Rep. Peters, Scott H. [D-CA-50] Scott Peters D CA H. 50 2023-07-20 False H001094 Rep. Hoyle, Val T. [D-OR-4] Val Hoyle D OR T. 4 2023-07-26 False F000476 Rep. Frost, Maxwell [D-FL-10] Maxwell Frost D FL 10 2023-08-29 False L000273 Rep. Leger Fernandez, Teresa [D-NM-3] Teresa Leger Fernandez D NM 3 2023-11-14 False L000562 Rep. Lynch, Stephen F. [D-MA-8] Stephen Lynch D MA F. 8 2023-12-05 False Q000023 Rep. Quigley, Mike [D-IL-5] Mike Quigley D IL 5 2024-06-04 False P000614 Rep. Pappas, Chris [D-NH-1] Chris Pappas D NH 1 2024-07-05 False T000481 Rep. Tlaib, Rashida [D-MI-12] Rashida Tlaib D MI 12 2024-07-10 False T000469 Rep. Tonko, Paul [D-NY-20] Paul Tonko D NY 20 2024-07-18 False Health Emergency medical services and trauma care 2023-08-17T19:30:23Z Government information and archives 2023-08-17T19:30:23Z Manufacturing 2023-08-17T19:30:23Z Prescription drugs 2023-08-17T19:30:23Z Health 2023-05-17T15:31:00Z

00 2023-04-28 Introduced in House 2024-01-17T17:42:28Z <p><b>Drug Shortage Prevention Act of 2023</b></p> <p>This bill requires drug manufacturers to notify the Food and Drug Administration (FDA) if there is an increased demand for certain critical essential medicines that may result in a shortage. </p> <p>Currently, drug manufacturers are required to notify the FDA in the event of a discontinuation or interruption in the supply of prescription drugs that are life-supporting, life-sustaining, or used for a debilitating disease or condition, including those used in medical emergencies, surgeries, or public health emergencies.</p> <p>The bill requires drug manufacturers to also notify the FDA if there is an increased demand for such drugs that lasts for at least six weeks and that may result in a shortage. Manufacturers must initially notify the FDA of the increased demand within 48 hours after this six-week period and must submit an additional notice within 30 days of the initial notification. The notice must include the reasons for the increased demand, the expected duration, and any other information the FDA requires. The bill's requirements apply to both prescription and nonprescription drugs. </p>

Display Title 45 2024-06-11T16:15:59Z Short Title(s) as Introduced 101 2024-05-24T13:40:23Z Introduced in House IH Official Title as Introduced 6 2024-03-18T20:42:34Z Introduced in House IH Introduced in House 2023-04-28T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-118hr3008ih/xml/BILLS-118hr3008ih.xml 2023-05-05 Referred to the Subcommittee on Health. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.